BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11494160)

  • 1. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
    J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
    Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
    J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
    Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
    Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
    Piketty C; Darragh TM; Heard I; Da Costa M; Bruneval P; Kazatchkine MD; Palefsky JM
    Sex Transm Dis; 2004 Feb; 31(2):96-9. PubMed ID: 14743072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
    J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.
    Rowhani-Rahbar A; Hawes SE; Sow PS; Toure P; Feng Q; Dem A; Dembele B; Critchlow CW; N'Doye I; Kiviat NB
    J Infect Dis; 2007 Sep; 196(6):887-94. PubMed ID: 17703420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women.
    Del Mistro A; Bertorelle R; Franzetti M; Cattelan A; Torrisi A; Giordani MT; Sposetti R; Bonoldi E; Sasset L; Bonaldi L; Minucci D; Chieco-Bianchi L
    Clin Infect Dis; 2004 Mar; 38(5):737-42. PubMed ID: 14986260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
    J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
    Heard I; Palefsky JM; Kazatchkine MD
    Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
    Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus typing in HIV-positive women.
    Hameed M; Fernandes H; Skurnick J; Moore D; Kloser P; Heller D
    Infect Dis Obstet Gynecol; 2001; 9(2):89-93. PubMed ID: 11495559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
    Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
    AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.